Ftse Mib
34.720,35
0,90%
DAX
19.473,63
1,32%
S&P 500
5.730,62
-0,26%
NASDAQ
18.132,18
-0,32%
Bitcoin
65.629,66
0,69%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tonix Pharmaceuticals Holding Corporation (TNXP) Tonix Pharmaceuticals Holding Corporation (TNXP) Notizie

TNXP

Tonix Pharmaceuticals (TNXP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TNXP
DataOraFonteTitoloSimboloCompagnia
27/09/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
27/09/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat MigrainesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/09/202423:09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/09/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/09/202423:03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/09/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat MigrainesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/09/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health EmergencyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/09/202423:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
10/09/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial OperationsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
09/09/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of AlbertaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/09/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeekNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
30/08/202423:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/08/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
28/08/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
26/08/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
21/08/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/08/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine IntoxicationNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/08/202412:00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/08/202423:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/08/202413:00GlobeNewswire Inc.Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health EmergencyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
15/08/202412:03Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/08/202414:00GlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor SummitNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/08/202414:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on PainNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/08/202414:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other PathogensNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
31/07/202414:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
30/07/202414:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on PainNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/07/202414:00GlobeNewswire Inc.Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
24/07/202423:14Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
10/07/202422:30GlobeNewswire Inc.Tonix Pharmaceuticals Announces Closing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
09/07/202415:15GlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TNXP

La tua Cronologia

COIN
BTADEUR
USOTC
FOSYF
Forsys Metals (PK)
TSX
RQP
RBC Target 2027 Canadian...
USOTC
TCEC
TransCoastal (CE)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network